Jacqueline Gerhart

9PUBLICATIONS
35CO-AUTHORS
Foetal development and medicineNutrigenomics and personalised nutritionInclusive educationInfant and child healthPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 21, 2026
A Phase 1 Multiple-Dose, Open-Label, Pharmacokinetic Study of Nirmatrelvir/Ritonavir in Healthy Lactating Women.

|Mar 13, 2026
Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID-19 and Severe Renal Impairment.

Jacqueline Gerhart, Candace R Bramson, Michelle Goulding

|Apr 09, 2025
Empowering Early-Career Scientists: Opportunities Through ASCPT Programs, Networks, and Communities.

Sheena Sharma, Jacqueline Gerhart, Iris K Minichmayr

|Jul 02, 2024
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population.

Fernando O Carreño, Jacqueline G Gerhart, Victória E Helfer

|Jan 04, 2024
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir.

Jacqueline Gerhart, Donna S Cox, Ravi Shankar P Singh

|May 24, 2022
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients.

Sara N Salerno, Edmund V Capparelli, Helen McIlleron

Pageof 2

Frequent Collaborators

5 joint publications

Daniel Gonzalez

3 joint publications

Fernando O Carreño

2 joint publications

Jennifer Hammond

2 joint publications

Andrea N Edginton